AngioDynamics, Inc. (ANGO)

AngioDynamics Income Statement

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 31, 2025	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Revenue	300.72	292.5	303.91	338.75	316.22	291.01
Revenue Growth (YoY)	2.73%	-3.76%	-10.28%	7.13%	8.66%	10.17%
Cost of Revenue	137.88	134.79	149.22	164.51	150.49	134.22
Gross Profit	162.84	157.71	154.7	174.25	165.73	156.79
Selling, General & Admin	149.69	145.6	144.18	144.45	134.01	117.22
Research & Development	26	25.85	31.32	29.69	30.48	36.39
Operating Expenses	186.09	181.77	188.54	192.93	183.95	171.75
Operating Income	-23.25	-24.06	-33.84	-18.68	-18.22	-14.96
Interest Expense	-0	-	-	-2.7	-0.69	-0.86
Interest & Investment Income	0.37	0.98	1.61	-	-	-
Other Non Operating Income (Expenses)	4.94	4.94	-0.82	-0.55	-0.79	0.09
EBT Excluding Unusual Items	-17.94	-18.14	-33.05	-21.94	-19.7	-15.73
Merger & Restructuring Charges	-14.15	-15.4	-18.13	-1.46	-0.7	-0
Impairment of Goodwill	-	-	-159.48	-14.55	-	-
Gain (Loss) on Sale of Assets	-	-	54.5	-	-	-0.39
Asset Writedown	-	-	-	-	-	-13.95
Legal Settlements	-0.42	-0.72	-34.94	-10	-7.63	-6.16
Other Unusual Items	0.31	0.22	-0.55	-6.5	-1.93	0.19
Pretax Income	-32.21	-34.03	-191.64	-54.44	-29.95	-36.05
Income Tax Expense	-0.11	-0.04	-7.29	-2	-3.4	-4.5
Earnings From Continuing Operations	-32.1	-33.99	-184.35	-52.44	-26.55	-31.55
Net Income	-32.1	-33.99	-184.35	-52.44	-26.55	-31.55
Net Income to Common	-32.1	-33.99	-184.35	-52.44	-26.55	-31.55
Shares Outstanding (Basic)	41	41	40	39	39	38
Shares Outstanding (Diluted)	41	41	40	39	39	38
Shares Change (YoY)	1.49%	1.67%	1.78%	1.21%	1.74%	1.00%
EPS (Basic)	-0.78	-0.83	-4.59	-1.33	-0.68	-0.82
EPS (Diluted)	-0.78	-0.83	-4.59	-1.33	-0.68	-0.82
Free Cash Flow	-17.61	-20.31	-35.69	-9.13	-22.9	10.38
Free Cash Flow Per Share	-0.43	-0.50	-0.89	-0.23	-0.59	0.27
Gross Margin	54.15%	53.92%	50.90%	51.44%	52.41%	53.88%
Operating Margin	-7.73%	-8.23%	-11.14%	-5.51%	-5.76%	-5.14%
Profit Margin	-10.67%	-11.62%	-60.66%	-15.48%	-8.39%	-10.84%
Free Cash Flow Margin	-5.85%	-6.94%	-11.74%	-2.70%	-7.24%	3.57%
EBITDA	-1.61	-1.66	-8.53	12.19	11.13	10.95
EBITDA Margin	-0.54%	-0.57%	-2.81%	3.60%	3.52%	3.76%
D&A For EBITDA	21.64	22.4	25.31	30.87	29.35	25.92
EBIT	-23.25	-24.06	-33.84	-18.68	-18.22	-14.96
EBIT Margin	-7.73%	-8.23%	-11.14%	-5.51%	-5.76%	-5.14%

Updated Oct 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q